![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: PALB2
December 19, 2023
The Path to Clinical Relevance: What a Study on RAD51C Reveals about Resolving VUS
Marcy Richardson, PhD discusses variant interpretation, VUS, and recategorizing missense genes with an example from Hu et al’s recent publication on RAD51C.
Genetic Testing
Genetic Testing Accuracy
PALB2
RAD51D
Variant of Unknown Significance
VUS
April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
Mayo Clinic and Dr. Fergus Couch collaborate with Ambry Genetics in the largest genetic study to date of women with breast cancer.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
HBOC
Mayo Clinic
NCCN
PALB2
RAD51D
February 6, 2017
Genetic Testing Accuracy Explained During the AmbrySpeaks-Los Angeles Event
Genetic Testing Accuracy Explained During the AmbrySpeaks-Los Angeles Event
Ambry Speaks Tour
AmbryShare
BRCA2
PALB2
Sanger Confirmation
December 23, 2016
New Research on Male Breast Cancer: Unexpected Results and Insights
Ambry Genetics, Huntsman Cancer Institute and Mayo Clinic conduct largest reported study of men with breast cancer undergoing multi-gene panel testing.
BRCA1 & 2
CHEK2
Huntsman Cancer Institute
Male Breast Cancer
Mayo Clinic
PALB2
